Drug Master File reporting on 77 active substances needs to be notified from next month

Published: 2004-05-27 06:56:00

Updated: 2004-05-27 06:56:00

The Korea Food and Drug Administration says that local pharmaceutical firms' drug master file (DMP) reporting of 77 active substances in terms of therapeutic category, which is divided into three groups, will begin from June 21 to the end of August, noting the full DMF application on these substa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK